Phase I Cetuximab and Concurrent Radio-chemotherapy

NCT00522886 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Cetuximab

Sponsor

Maastricht Radiation Oncology

Collaborators

[object Object]
[object Object]